rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2011-4-11
|
pubmed:abstractText |
Estrogen receptor-? (ER) is an important target both for therapeutic compounds and endocrine disrupting chemicals (EDCs); however, the mechanisms involved in chemical modulation of regulating ER transcriptional activity are inadequately understood. Here, we report the development of a high content analysis-based assay to describe ER activity that uniquely exploits a microscopically visible multi-copy integration of an ER-regulated promoter. Through automated single-cell analyses, we simultaneously quantified promoter occupancy, recruitment of transcriptional cofactors and large-scale chromatin changes in response to a panel of ER ligands and EDCs. Image-derived multi-parametric data was used to classify a panel of ligand responses at high resolution. We propose this system as a novel technology providing new mechanistic insights into EDC activities in a manner useful for both basic mechanistic studies and drug testing.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-hydroxytamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Endocrine Disruptors,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Green Fluorescent Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Phenols,
http://linkedlifedata.com/resource/pubmed/chemical/Raloxifene,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/bisphenol A,
http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1879-0038
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
477
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
42-52
|
pubmed:meshHeading |
pubmed-meshheading:21256200-Blotting, Western,
pubmed-meshheading:21256200-Cell Line, Tumor,
pubmed-meshheading:21256200-Cluster Analysis,
pubmed-meshheading:21256200-Endocrine Disruptors,
pubmed-meshheading:21256200-Estradiol,
pubmed-meshheading:21256200-Estrogen Antagonists,
pubmed-meshheading:21256200-Estrogen Receptor alpha,
pubmed-meshheading:21256200-Green Fluorescent Proteins,
pubmed-meshheading:21256200-HeLa Cells,
pubmed-meshheading:21256200-Humans,
pubmed-meshheading:21256200-Microscopy, Fluorescence,
pubmed-meshheading:21256200-Phenols,
pubmed-meshheading:21256200-Principal Component Analysis,
pubmed-meshheading:21256200-Promoter Regions, Genetic,
pubmed-meshheading:21256200-Raloxifene,
pubmed-meshheading:21256200-Reproducibility of Results,
pubmed-meshheading:21256200-Tamoxifen
|
pubmed:year |
2011
|
pubmed:articleTitle |
High content imaging-based assay to classify estrogen receptor-? ligands based on defined mechanistic outcomes.
|
pubmed:affiliation |
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|